At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
AXIOS Stent with Electrocautery Enhanced Delivery Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AXIOS Stent With Electrocautery Enhanced Delivery System
In Brief
A clinical study evaluating AXIOS Stent with Electrocautery Enhanced Delivery System for Pancreatic Pseudocyst(s). Completed, enrolled 30 participants across 8 sites.
Detailed Summary
The purpose of this study is to demonstrate the safety and effectiveness of the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic transenteric drainage of pancreatic pseudocysts.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Pseudocyst(s)
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 2014
Enrollment StartJun 2014
Primary CompletionJan 2015
Study CompletionMar 2015
TodayJul 2026
First PostedMay 23, 2014
Enrollment StartJun 1, 2014
Primary CompletionJan 1, 2015
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.1 years ago
Interventions
AXIOS Stent with Electrocautery Enhanced Delivery Systemdevice
Endoscopy with ultrasonography to implant AXIOS stent using electrocautery enhanced delivery system to allow drainage of pancreatic pseudocyst. Removal of AXIOS stent after 30 or 60 days.